Karyopharm Therapeutics Inc (KPTI) Insider Trading
- $10,245,912.22
- $142,165,901.96
- Oct. 4, 2024
- Ltd Chione
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 16, 2019 | CEO | 10,000 | $12.00 | Sell | $120,000.00 | |
Feb. 27, 2019 | Major Shareholder | 1,481,643 | $4.81 | Sell | $7,126,702.83 | |
Feb. 25, 2019 | Major Shareholder | 800,000 | $4.99 | Sell | $3,992,000.00 | |
Jan. 7, 2019 | Insider | 12,500 | $10.23 | Sell | $127,875.00 | |
Dec. 7, 2018 | Insider | 12,500 | $10.11 | Sell | $126,375.00 | |
Nov. 26, 2018 | CEO | 9,600 | $11.00 | Sell | $105,600.00 | |
Nov. 19, 2018 | Insider | 400 | $11.14 | Sell | $4,456.00 | |
Nov. 7, 2018 | Insider | 12,500 | $11.65 | Sell | $145,625.00 | |
Oct. 18, 2018 | Insider | 10,000 | $12.63 | Sell | $126,300.00 | |
Oct. 8, 2018 | Insider | 12,500 | $15.75 | Sell | $196,875.00 | |
Sept. 18, 2018 | CEO | 10,000 | $18.26 | Sell | $182,600.00 | |
Sept. 10, 2018 | EVP | 10,000 | $18.90 | Sell | $189,000.00 | |
Sept. 7, 2018 | Insider | 12,500 | $19.31 | Sell | $241,375.00 | |
Sept. 6, 2018 | Major Shareholder | 164,800 | $21.05 | Sell | $3,469,040.00 | |
Sept. 4, 2018 | Major Shareholder | 251,468 | $20.94 | Sell | $5,265,739.92 | |
Aug. 31, 2018 | Major Shareholder | 11,468 | $21.05 | Sell | $241,401.40 | |
Aug. 29, 2018 | Director | 2,500 | $20.00 | Sell | $50,000.00 | |
Aug. 29, 2018 | Major Shareholder | 214,026 | $19.52 | Sell | $4,177,787.52 | |
Aug. 27, 2018 | Major Shareholder | 14,026 | $18.52 | Sell | $259,761.52 | |
Aug. 20, 2018 | CEO | 10,000 | $17.46 | Sell | $174,600.00 | |
Aug. 9, 2018 | Major Shareholder | 80,876 | $18.52 | Sell | $1,497,823.52 | |
Aug. 7, 2018 | Major Shareholder | 10,602 | $18.60 | Sell | $197,197.20 | |
Aug. 7, 2018 | CEO | 12,500 | $18.04 | Sell | $225,500.00 | |
July 25, 2018 | Major Shareholder | 30,039 | $18.65 | Sell | $560,227.35 | |
July 23, 2018 | Major Shareholder | 20,000 | $18.66 | Sell | $373,200.00 | |
July 20, 2018 | Major Shareholder | 126,742 | $18.97 | Sell | $2,404,295.74 | |
July 18, 2018 | CEO | 10,000 | $18.27 | Sell | $182,700.00 | |
July 18, 2018 | Major Shareholder | 50,000 | $18.52 | Sell | $926,000.00 | |
July 16, 2018 | Major Shareholder | 2,654 | $18.52 | Sell | $49,152.08 | |
July 9, 2018 | Insider | 12,500 | $18.72 | Sell | $234,000.00 | |
June 18, 2018 | Insider | 10,000 | $18.66 | Sell | $186,600.00 | |
June 7, 2018 | Insider | 10,000 | $17.30 | Sell | $173,000.00 | |
May 18, 2018 | CEO | 10,000 | $19.39 | Sell | $193,900.00 | |
May 10, 2018 | EVP | 2,000 | $18.01 | Sell | $36,020.00 | |
May 7, 2018 | Insider | 10,000 | $16.77 | Sell | $167,700.00 | |
April 18, 2018 | CEO | 10,000 | $14.79 | Sell | $147,900.00 | |
April 9, 2018 | Insider | 10,000 | $12.48 | Sell | $124,800.00 | |
March 19, 2018 | CEO | 10,000 | $15.29 | Sell | $152,900.00 | |
March 12, 2018 | Director | 2,500 | $17.01 | Sell | $42,525.00 | |
March 7, 2018 | Insider | 10,000 | $16.15 | Sell | $161,500.00 | |
March 5, 2018 | EVP | 2,500 | $16.03 | Sell | $40,075.00 | |
Feb. 20, 2018 | CEO | 10,000 | $14.79 | Sell | $147,900.00 | |
Feb. 16, 2018 | EVP | 2,500 | $15.01 | Sell | $37,525.00 | |
Feb. 7, 2018 | EVP | 1,500 | $13.00 | Sell | $19,500.00 | |
Feb. 7, 2018 | Insider | 10,000 | $12.50 | Sell | $125,000.00 | |
Jan. 18, 2018 | CEO | 10,000 | $10.09 | Sell | $100,900.00 | |
Jan. 8, 2018 | Insider | 10,000 | $10.08 | Sell | $100,800.00 | |
Dec. 18, 2017 | CEO | 10,000 | $9.16 | Sell | $91,600.00 | |
Dec. 12, 2017 | SVP | 27,042 | $10.28 | Sell | $277,991.76 | |
Dec. 7, 2017 | Insider | 10,000 | $10.39 | Sell | $103,900.00 |
Insiders are both buying and selling Karyopharm Therapeutics Inc stock.
The insider traders at Karyopharm Therapeutics Inc are: Ltd Chione, Michael Kauffman, Sharon Shacham, Richard A Paulson, Christopher Brett Primiano, Mansoor Raza Mirza, Marcin Czernik, Michael Mason, Deepika Pakianathan, Jatin Shah, Stuart Poulton, Sohanya Roshan Cheng, Reshma Rangwala, Ran Frenkel, Garen G Bohlin, Stephen Mitchener, Michael Mano, Tanya Lewis, John Demaree, Justin A Renz, Ltd Plio, Paul Brannelly, Paulson Richard A., and Barry E Greene
The most active insider trader at Karyopharm Therapeutics Inc is Ltd Chione with 36 trades.
Ltd Chione has sold the most Karyopharm Therapeutics Inc stock with a total value of $91,689,798.39.
Deepika Pakianathan has bought the most Karyopharm Therapeutics Inc stock with a total value of $10,995,453.42.
The most recent insider trade for Karyopharm Therapeutics Inc was on Oct. 4, 2024.
The single biggest insider buy for Karyopharm Therapeutics Inc was from Deepika Pakianathan with a total value of $5,000,000.00 on Nov. 12, 2013.
The single biggest insider sell for Karyopharm Therapeutics Inc was from Ltd Plio with a total value of $17,770,000.00 on July 23, 2014.